Urogenital Neoplasm
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients (NCT02602067) | sigma-tau i.f.r. S.p.A. | 2015-11-01 |
| The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery (NCT02728921) | Region Skane | 2014-04-01 |
Track Urogenital Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.